 Connection
Charles Daley to Treatment Failure
This is a "connection" page, showing publications Charles Daley has written about Treatment Failure.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.245 |
|
|
|
-
van Ingen J, Totten SE, Heifets LB, Boeree MJ, Daley CL. Drug susceptibility testing and pharmacokinetics question current treatment regimens in Mycobacterium simiae complex disease. Int J Antimicrob Agents. 2012 Feb; 39(2):173-6.
Score: 0.081
-
Moreira-Sousa D, Martins B, Aguiar A, Pinheiro M, Akkerman OW, Aksamit TR, Aliberti S, Andrejak C, Daley CL, van Ingen J, Lange C, Lipman M, Loebinger MR, Jankovic Makek M, Morimoto K, Thomson R, Wagner D, Winthrop KL, Yim JJ, Duarte R. Management of nontuberculous mycobacterial Pulmonary disease refractory to guideline-based therapy: A systematic review. Pulmonology. 2026 Dec; 32(1):2632467.
Score: 0.054
-
Moreira-Sousa D, Martins B, Aguiar A, Pinheiro M, Akkerman O, Aksamit TR, Aliberti S, Andrejak C, Daley CL, van Ingen J, Lange C, Lipman M, Loebinger MR, Jankovic Makek M, Morimoto K, Thomson RM, Wagner D, Winthrop KL, Yim JJ, Duarte R. Consensus on the management of refractory nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2026 Jan; 67(1).
Score: 0.054
-
Moon SM, Jhun BW, Daley CL, Koh WJ. Unresolved issues in treatment outcome definitions for nontuberculous mycobacterial pulmonary disease. Eur Respir J. 2019 05; 53(5).
Score: 0.034
-
Walter ND, Strong M, Belknap R, Ordway DJ, Daley CL, Chan ED. Translating basic science insight into public health action for multidrug- and extensively drug-resistant tuberculosis. Respirology. 2012 Jul; 17(5):772-91.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|